Literature DB >> 23529994

High rates of fructose malabsorption are associated with reduced liver fat in obese African Americans.

Ryan W Walker1, Kim-Anne Lê, Jaime Davis, Tanya L Alderete, Rebecca Cherry, Sylvie Lebel, Michael I Goran.   

Abstract

OBJECTIVE: African Americans commonly have lower liver fat accumulation than Hispanics, despite a similar propensity for obesity. Both ethnicities exhibit high consumption of fructose-containing beverages, which has been associated with high liver fat owing to the lipogenic properties of fructose. Therefore, differences in fructose absorption may be an important factor in regulating liver fat deposition. We hypothesized that fructose malabsorption in African Americans may reduce hepatic delivery of fructose, thus contributing to lower liver fat deposition compared to Hispanics.
METHODS: Thirty-seven obese young adults aged 21.4 ± 2.1 years (16 African American, 21 Hispanic) underwent a 3-hour hydrogen (H2) breath test to assess fructose malabsorption. Magnetic resonance imaging was used to determine visceral and subcutaneous adipose tissue volume and liver fat. Fructose malabsorption was expressed as an area under the curve for H2 production (H2 AUC).
RESULTS: Compared to Hispanics, African Americans had lower liver fat (5.4% ± 5.0% vs 8.9% ± 2.3%, p = 0.02) and a higher prevalence of fructose malabsorption (75.0% vs 42.9%; p = 0.05). Liver fat was negatively related to the extent of fructose malabsorption in African Americans (r = -0.53, p = 0.03), and this relationship was independent of the volumes of total fat and subcutaneous and visceral adipose tissue. There were no significant relationships between liver fat and fructose malabsorption in Hispanics.
CONCLUSION: African Americans have both a higher prevalence and a greater magnitude of fructose malabsorption than Hispanics. In African Americans, fructose malabsorption was negatively correlated with liver fat, which may be protective against fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23529994     DOI: 10.1080/07315724.2012.10720445

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  15 in total

Review 1.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Race/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Rosemay A Remigio-Baker; Matthew A Allison; Nketi I Forbang; Rohit Loomba; Cheryl A M Anderson; Matthew Budoff; Jeffrey B Schwimmer; Roger S Blumenthal; Pamela Ouyang; Michael H Criqui
Journal:  Atherosclerosis       Date:  2016-11-17       Impact factor: 5.162

Review 3.  Molecular aspects of fructose metabolism and metabolic disease.

Authors:  Mark A Herman; Morris J Birnbaum
Journal:  Cell Metab       Date:  2021-10-06       Impact factor: 27.287

Review 4.  New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.

Authors:  Karim R Saab; Jessica Kendrick; Joseph M Yracheta; Miguel A Lanaspa; Maisha Pollard; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 10.121

5.  Oral fructose absorption in obese children with non-alcoholic fatty liver disease.

Authors:  J S Sullivan; M T Le; Z Pan; C Rivard; K Love-Osborne; K Robbins; R J Johnson; R J Sokol; S S Sundaram
Journal:  Pediatr Obes       Date:  2014-06-24       Impact factor: 4.000

Review 6.  Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field.

Authors:  Miriam B Vos
Journal:  Curr Opin Lipidol       Date:  2014-02       Impact factor: 4.776

Review 7.  Clinical research strategies for fructose metabolism.

Authors:  Maren R Laughlin; John P Bantle; Peter J Havel; Elizabeth Parks; David M Klurfeld; Karen Teff; Padma Maruvada
Journal:  Adv Nutr       Date:  2014-05-14       Impact factor: 8.701

Review 8.  The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease.

Authors:  Silvia M Ferolla; Geyza N A Armiliato; Cláudia A Couto; Teresa C A Ferrari
Journal:  Nutrients       Date:  2014-12-03       Impact factor: 5.717

9.  Fructose: a key factor in the development of metabolic syndrome and hypertension.

Authors:  Zeid Khitan; Dong Hyun Kim
Journal:  J Nutr Metab       Date:  2013-05-25

Review 10.  Sugar, uric acid, and the etiology of diabetes and obesity.

Authors:  Richard J Johnson; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Mohamed Shafiu; Shikha Sundaram; Myphuong Le; Takuji Ishimoto; Yuri Y Sautin; Miguel A Lanaspa
Journal:  Diabetes       Date:  2013-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.